Browsing Tag
Qurient
1 post
What makes Qurient’s CDK7 inhibitor pairing with Synaffix’s exatecan payload a potential game changer?
Synaffix and Qurient team up on a dual-payload ADC using exatecan and CDK7 inhibitor, aiming to reshape targeted cancer therapy and boost Lonza’s platform strategy.
September 27, 2025